Insider plans 1,663-share Form 144 sale at EXPO

A person associated with EXPO has filed a Form 144 notice to sell 1,663 shares of common stock through Morgan Stanley Smith Barney LLC on or around 01/15/2026 on the NASDAQ.

Rhea-AI Filing Summary

A person associated with EXPO has filed a Form 144 notice to sell 1,663 shares of common stock through Morgan Stanley Smith Barney LLC on or around 01/15/2026 on the NASDAQ. These shares were acquired the same day by exercising stock options and paid for in cash.

The notice also lists prior Rule 10b5-1 plan sales for Catherine Corrigan in the past three months, including 3,225 shares sold on 12/15/2025 for gross proceeds of $240,171.23, and additional sales of 3,225 shares and 1,675 shares on 11/17/2025 for gross proceeds of $226,411.13 and $118,487.32, respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the EXPO Form 144 filing disclose?

The Form 144 filing discloses an intention to sell 1,663 shares of EXPO common stock, with the shares to be sold on or about 01/15/2026 on the NASDAQ.

How were the 1,663 EXPO shares being sold under Form 144 acquired?

The 1,663 shares being sold were acquired on 01/15/2026 through an exercise of stock options from the issuer, paid for in cash.

Which broker is handling the planned EXPO share sale in this Form 144?

The planned sale of 1,663 EXPO common shares is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, New York, NY 10004.

What recent EXPO share sales are listed in the past 3 months section?

The filing lists Rule 10b5-1 sales for Catherine Corrigan, including 3,225 shares sold on 12/15/2025 and additional sales of 3,225 shares and 1,675 shares on 11/17/2025.

What gross proceeds are reported for recent EXPO stock sales?

Reported gross proceeds include $240,171.23 for 3,225 shares sold on 12/15/2025, and $226,411.13 plus $118,487.32 for sales totaling 4,900 shares on 11/17/2025.

Is the EXPO Form 144 sale connected to a Rule 10b5-1 trading plan?

The section on sales during the past 3 months identifies them as 10b5-1 sales for Catherine Corrigan, indicating those prior transactions were made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/15/2026 - 04:29 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001552213
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	EXPONENT, INC.
SEC File Number	000-18655
Address of Issuer	149 COMMONWEALTH DRIVE MENLO PARK CALIFORNIA 94025
Phone	6503269400
Name of Person for Whose Account the Securities are To Be Sold	CATHERINE CORRIGAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1663	120168.38	49887226	01/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2026	Exercise of Stock Options	Issuer			1663	01/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CATHERINE CORRIGAN 149 COMMONWEALTH DRIVE MENLO PARK CA 94025	Common	12/15/2025	3225	240171.23
10b5-1 Sales for CATHERINE CORRIGAN 149 COMMONWEALTH DRIVE MENLO PARK CA 94025	Common	11/17/2025	3225	226411.13
10b5-1 Sales for CATHERINE CORRIGAN 149 COMMONWEALTH DRIVE MENLO PARK CA 94025	Common	11/17/2025	1675	118487.32

144: Remarks and Signature

Remarks
Date of Notice	01/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Catherine Corrigan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)